Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

O'Mahony DG, Ramus SJ, Southey MC, Meagher NS, Hadjisavvas A, John EM, Hamann U, Imyanitov EN, Andrulis IL, Sharma P, Daly MB, Hake CR, Weitzel JN, Jakubowska A, Godwin AK, Arason A, Bane A, Simard J, Soucy P, Caligo MA, Mai PL, Claes KBM, Teixeira MR, Chung WK, Lazaro C, Hulick PJ, Toland AE, Pedersen IS, HEBON Investigators, Neuhausen SL, Vega A, de la Hoya M, Nevanlinna H, Dhawan M, Zampiga V, Danesi R, Varesco L, Gismondi V, Vellone VG, James PA, Janavicius R, Nikitina-Zake L, Nielsen FC, van Overeem Hansen T, Pejovic T, Borg A, Rantala J, Offit K, Montagna M, Nathanson KL, Domchek SM, Osorio A, García MJ, Karlan BY, GEMO Study Collaborators, De Fazio A, Bowtell D, AOCS Group, McGuffog L, Leslie G, Parsons MT, Dörk T, Speith LM, Dos Santos ES, da Costa AABA, Radice P, Peterlongo P, Papi L, Engel C, Hahnen E, Schmutzler RK, Wappenschmidt B, Easton DF, Tischkowitz M, Singer CF, Tan YY, Whittemore AS, Sieh W, Brenton JD, Yannoukakos D, Fostira F, Konstantopoulou I, Soukupova J, Vocka M, CZECANCA Consortium, Chenevix-Trench G, Pharoah PDP, Antoniou AC, Goldgar DE, Spurdle AB, Michailidou K, Consortium of Investigators of Modifiers of BRCA1/2, Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium

Open source

DOI: 10.1038/s41416-023-02263-5
Published: 2023 Jun
Container: British journal of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41416-023-02263-5,
  title = {Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.},
  author = {O'Mahony DG and Ramus SJ and Southey MC and Meagher NS and Hadjisavvas A and John EM and Hamann U and Imyanitov EN and Andrulis IL and Sharma P and Daly MB and Hake CR and Weitzel JN and Jakubowska A and Godwin AK and Arason A and Bane A and Simard J and Soucy P and Caligo MA and Mai PL and Claes KBM and Teixeira MR and Chung WK and Lazaro C and Hulick PJ and Toland AE and Pedersen IS and HEBON Investigators and Neuhausen SL and Vega A and de la Hoya M and Nevanlinna H and Dhawan M and Zampiga V and Danesi R and Varesco L and Gismondi V and Vellone VG and James PA and Janavicius R and Nikitina-Zake L and Nielsen FC and van Overeem Hansen T and Pejovic T and Borg A and Rantala J and Offit K and Montagna M and Nathanson KL and Domchek SM and Osorio A and García MJ and Karlan BY and GEMO Study Collaborators and De Fazio A and Bowtell D and AOCS Group and McGuffog L and Leslie G and Parsons MT and Dörk T and Speith LM and Dos Santos ES and da Costa AABA and Radice P and Peterlongo P and Papi L and Engel C and Hahnen E and Schmutzler RK and Wappenschmidt B and Easton DF and Tischkowitz M and Singer CF and Tan YY and Whittemore AS and Sieh W and Brenton JD and Yannoukakos D and Fostira F and Konstantopoulou I and Soukupova J and Vocka M and CZECANCA Consortium and Chenevix-Trench G and Pharoah PDP and Antoniou AC and Goldgar DE and Spurdle AB and Michailidou K and Consortium of Investigators of Modifiers of BRCA1/2 and Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium},
  year = {2023},
  journal = {British journal of cancer},
  doi = {10.1038/s41416-023-02263-5},
  url = {https://doi.org/10.1038/s41416-023-02263-5}
}

RIS

TY  - JOUR
TI  - Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
AU  - O'Mahony DG
AU  - Ramus SJ
AU  - Southey MC
AU  - Meagher NS
AU  - Hadjisavvas A
AU  - John EM
AU  - Hamann U
AU  - Imyanitov EN
AU  - Andrulis IL
AU  - Sharma P
AU  - Daly MB
AU  - Hake CR
AU  - Weitzel JN
AU  - Jakubowska A
AU  - Godwin AK
AU  - Arason A
AU  - Bane A
AU  - Simard J
AU  - Soucy P
AU  - Caligo MA
AU  - Mai PL
AU  - Claes KBM
AU  - Teixeira MR
AU  - Chung WK
AU  - Lazaro C
AU  - Hulick PJ
AU  - Toland AE
AU  - Pedersen IS
AU  - HEBON Investigators
AU  - Neuhausen SL
AU  - Vega A
AU  - de la Hoya M
AU  - Nevanlinna H
AU  - Dhawan M
AU  - Zampiga V
AU  - Danesi R
AU  - Varesco L
AU  - Gismondi V
AU  - Vellone VG
AU  - James PA
AU  - Janavicius R
AU  - Nikitina-Zake L
AU  - Nielsen FC
AU  - van Overeem Hansen T
AU  - Pejovic T
AU  - Borg A
AU  - Rantala J
AU  - Offit K
AU  - Montagna M
AU  - Nathanson KL
AU  - Domchek SM
AU  - Osorio A
AU  - García MJ
AU  - Karlan BY
AU  - GEMO Study Collaborators
AU  - De Fazio A
AU  - Bowtell D
AU  - AOCS Group
AU  - McGuffog L
AU  - Leslie G
AU  - Parsons MT
AU  - Dörk T
AU  - Speith LM
AU  - Dos Santos ES
AU  - da Costa AABA
AU  - Radice P
AU  - Peterlongo P
AU  - Papi L
AU  - Engel C
AU  - Hahnen E
AU  - Schmutzler RK
AU  - Wappenschmidt B
AU  - Easton DF
AU  - Tischkowitz M
AU  - Singer CF
AU  - Tan YY
AU  - Whittemore AS
AU  - Sieh W
AU  - Brenton JD
AU  - Yannoukakos D
AU  - Fostira F
AU  - Konstantopoulou I
AU  - Soukupova J
AU  - Vocka M
AU  - CZECANCA Consortium
AU  - Chenevix-Trench G
AU  - Pharoah PDP
AU  - Antoniou AC
AU  - Goldgar DE
AU  - Spurdle AB
AU  - Michailidou K
AU  - Consortium of Investigators of Modifiers of BRCA1/2
AU  - Evidence-based Network for the Interpretation of Germline Mutant Alleles Consortium
PY  - 2023
JO  - British journal of cancer
DO  - 10.1038/s41416-023-02263-5
UR  - https://doi.org/10.1038/s41416-023-02263-5
ER  -

APA

DG, O., SJ, R., MC, S., NS, M., A, H., EM, J., U, H., EN, I., IL, A., P, S., MB, D., CR, H., JN, W., A, J., AK, G., A, A., A, B., J, S., P, S., MA, C., PL, M., KBM, C., MR, T., WK, C., C, L., PJ, H., AE, T., IS, P., Investigators, H., SL, N., A, V., M, D. L. H., H, N., M, D., V, Z., R, D., L, V., V, G., VG, V., PA, J., R, J., L, N., FC, N., T, V. O. H., T, P., A, B., J, R., K, O., M, M., KL, N., SM, D., A, O., MJ, G., BY, K., Collaborators, G. S., A, D. F., D, B., Group, A., L, M., G, L., MT, P., T, D., LM, S., ES, D. S., AABA, D. C., P, R., P, P., L, P., C, E., E, H., RK, S., B, W., DF, E., M, T., CF, S., YY, T., AS, W., W, S., JD, B., D, Y., F, F., I, K., J, S., M, V., Consortium, C., G, C., PDP, P., AC, A., DE, G., AB, S., K, M., BRCA1/2, C. O. I. O. M. O., & Consortium, E. N. F. T. I. O. G. M. A. (2023). Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.. British journal of cancer. https://doi.org/10.1038/s41416-023-02263-5

Source records

pubmed · retrieved 2026-09-26T10:43:37.112Z